NDAORALTABLET, EXTENDED RELEASE
Lifecycle
Pre-Launch
Data completeness
2/8 — Basic
KAON CL (potassium chloride) by Ascentage Pharma is clinical pharmacology the potassium ion is the principal intracellular cation of most body tissues. Approved for bowel preparation, heart failure.
Drug data last refreshed 2w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
KAON CL is an oral extended-release potassium chloride supplement that replaces depleted potassium in patients with hypokalemia. It works by replenishing intracellular potassium, an essential cation required for nerve impulse transmission, muscle contraction, and normal renal function. The product is indicated for bowel preparation and heart failure management.
Pre-Launch
As a pre-launch product from Ascentage Pharma, this represents an early-stage commercial opportunity with potential for team expansion during regulatory approval and market entry.
Mechanism of Action
CLINICAL PHARMACOLOGY The potassium ion is the principal intracellular cation of most body tissues. Potassium ions participate in a number of essential physiological processes including the maintenance of intracellular tonicity; the transmission of nerve impulses; the contraction of cardiac,…
Worked on KAON CL at Ascentage Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.